Do Myoepithelial Cells Hold the Key for Breast Tumor Progression?
暂无分享,去创建一个
Kornelia Polyak | K. Polyak | M. Hu | Min Hu | Min Hu
[1] P. Quesenberry,et al. Stem Cells and Prenatal Origin of Breast Cancer , 2004, Cancer Causes & Control.
[2] M. Stratton,et al. Genetic alterations in ‘normal’ luminal and myoepithelial cells of the breast , 1999, The Journal of pathology.
[3] S. Devries,et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.
[4] T. Ratliff. TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .
[5] F. Miller,et al. Multipotent human breast stem cell line MCF1OAT. , 1996, International journal of oncology.
[6] Yudong D. He,et al. Expression profiling predicts outcome in breast cancer , 2002, Breast Cancer Research.
[7] Garrison Fh,et al. [History of cancer]. , 1926, Il Policlinico. Sezione pratica.
[8] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[9] Å. Borg,et al. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors , 2005, Modern Pathology.
[10] T. Tlsty,et al. Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.
[11] Sanford H Barsky,et al. Human breast carcinoma desmoplasia is PDGF initiated , 2000, Oncogene.
[12] H. Höfler,et al. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH , 2000, International journal of cancer.
[13] B. Unsworth,et al. Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro. , 1975, Journal of the National Cancer Institute.
[14] S. Barsky,et al. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype , 2000, Oncogene.
[15] G. Bratthauer,et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.
[16] A. Gown,et al. Detection of Stromal Invasion in Breast Cancer: The Myoepithelial Markers , 2000, Advances in anatomic pathology.
[17] R. D'Amato,et al. Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] D. Stoppa-Lyonnet,et al. High-risk lesions in high-risk women: a high-risk formalin-based biology! , 2004, Journal of Clinical Oncology.
[19] G. Viale,et al. p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast , 2001, The American journal of surgical pathology.
[20] T. Calcaterra,et al. Establishment and characterization of a novel human myoepithelial cell line and matrix-producing xenograft from a parotid basal cell adenocarcinoma , 1996, In Vitro Cellular & Developmental Biology - Animal.
[21] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[22] J. Tobacman,et al. Steroid sulfatase activity and expression in mammary myoepithelial cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[23] G. Dontu,et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.
[24] N. Bundred,et al. Molecular markers and therapeutic targets in ductal carcinoma in situ , 2002, Microscopy research and technique.
[25] H. Thornton,et al. Ductal carcinoma-in-situ of the breast , 1992, The Lancet.
[26] B. Gusterson,et al. Breast development gives insights into breast disease , 1998, Histopathology.
[27] E. Lane,et al. The development of epithelial phenotypes in the human fetal and infant breast , 1998, The Journal of pathology.
[28] G. Bratthauer,et al. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers , 2003, Breast Cancer Research.
[29] J. Russo,et al. Atlas and Histologic Classification of Tumors of the Rat Mammary Gland , 2000, Journal of Mammary Gland Biology and Neoplasia.
[30] Alan Mackay,et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.
[31] S. Lemeshow,et al. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.
[32] Sanford H Barsky,et al. Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. , 2003, Experimental and molecular pathology.
[33] L. Cupples,et al. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. , 2002, The American journal of pathology.
[34] V. Steele,et al. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. , 2003, Mutation research.
[35] B. Unsworth,et al. Breast Cancer: Induction of Differentiation by Embryonic Tissue , 1973, Science.
[36] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[37] Mina J Bissell,et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.
[38] Ana M Soto,et al. The stroma as a crucial target in rat mammary gland carcinogenesis , 2004, Journal of Cell Science.
[39] T. Tlsty,et al. Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.
[40] M. Shekhar,et al. Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast , 2003, Breast Cancer Research.
[41] Z. Shao,et al. The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[42] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[43] J. Tobacman. Filament Disassembly and Loss of Mammary Myoepithelial Cells after Exposure to λ-Carrageenan , 1997 .
[44] A. Gerdes,et al. Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue , 1995, International journal of cancer.
[45] P. Sommer,et al. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. , 1997, The American journal of pathology.
[46] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[47] L. Gaboury,et al. Basal Cells of Second Trimester Fetal Breasts: Immunohistochemical Study of Myoepithelial Precursors , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[48] Martin A. Nowak,et al. The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.
[49] S. Barsky,et al. The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.
[50] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[51] C. Morrison,et al. Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets , 2004, Cancer Research.
[52] R. Shore,et al. The risk of breast cancer after irradiation of the thymus in infancy. , 1989, The New England journal of medicine.
[53] M. Stratton,et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.
[54] S. Swain,et al. Ductal carcinoma in situ, complexities and challenges. , 2004, Journal of the National Cancer Institute.
[55] Mina J Bissell,et al. The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.
[56] K. Malone,et al. Age-Specific Incidence Rates of In situ Breast Carcinomas by Histologic Type, 1980 to 2001 , 2005, Cancer Epidemiology Biomarkers & Prevention.
[57] F. Miller. Xenograft Models of Premalignant Breast Disease , 2000, Journal of Mammary Gland Biology and Neoplasia.
[58] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[59] F. Miller,et al. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. , 2000, Journal of the National Cancer Institute.
[60] J. Varley,et al. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma , 1997, Oncogene.
[61] F. Kittrell,et al. Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia , 2005, Journal of Cell Science.
[62] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[63] T. Ushijima,et al. Detection and interpretation of altered methylation patterns in cancer cells , 2005, Nature Reviews Cancer.
[64] Mina J Bissell,et al. Tumor reversion: Correction of malignant behavior by microenvironmental cues , 2003, International journal of cancer.
[65] D. Trichopoulos. Intrauterine environment, mammary gland mass and breast cancer risk , 2002, Breast Cancer Research.
[66] J. Tobacman. Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan. , 1997, Cancer research.
[67] K. Hunter,et al. Host genetics and tumour metastasis , 2004, British Journal of Cancer.
[68] T. Hunt,et al. Multiple Organ Engraftment by Bone‐Marrow‐Derived Myofibroblasts and Fibroblasts in Bone‐Marrow‐Transplanted Mice , 2003, Stem cells.
[69] S. Lakhani,et al. Molecular evolution of breast cancer , 2005, The Journal of pathology.
[70] Jun Yao,et al. Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.
[71] M. Washington,et al. TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.
[72] M. Bissell,et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.
[73] G. Felsenfeld,et al. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.
[74] S. Barsky,et al. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. , 2000, Cancer letters.
[75] Holly Dressman,et al. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. , 2003, Human molecular genetics.
[76] S. Hayward,et al. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. , 2005, Oncogene.
[77] J. Marks,et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. , 2001, Cancer research.
[78] R. Poulsom,et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon , 2002, Gut.
[79] Generoso Bevilacqua,et al. Bio-morphological events in the development of the human female mammary gland from fetal age to puberty , 2000, Virchows Archiv.
[80] S. Hayward,et al. Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks , 2005, Oncogene.
[81] Sushanta K Banerjee,et al. Neuropilin‐1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancer , 2002, International journal of cancer.
[82] L. Kiemeney,et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] C. Foster,et al. Molecular and genetic abnormalities in radial scar. , 2002, Human pathology.
[84] Satoshi Matsumoto,et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.
[85] D. Santini,et al. Immunocytochemical Expression of Epidermal Growth Factor Receptor in Myoepithelial Cells of the Breast , 2002, Applied immunohistochemistry & molecular morphology : AIMM.
[86] M J Bissell,et al. Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.
[87] J. Thiery,et al. The importance of being a myoepithelial cell , 2002, Breast Cancer Research.
[88] P. Goss,et al. Breast cancer risk following irradiation for Hodgkin's disease. , 2000, Cancer treatment reviews.
[89] S. Lakhani,et al. The mammary myoepithelial cell - Cinderella or ugly sister? , 2000, Breast Cancer Research.
[90] Zena Werb,et al. Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.
[91] M J O'Hare,et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[92] R. Weinberg,et al. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.
[93] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[94] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[95] A. Thor,et al. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.
[96] Russell Vang,et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion , 2003, Breast Cancer Research.
[97] S. Love,et al. ‘Revertant’ DCIS in human axillary breast carcinoma metastases , 1997, The Journal of pathology.
[98] J. Shaw,et al. Primary breast myoepithelial cells exert an invasion‐suppressor effect on breast cancer cells via paracrine down‐regulation of MMP expression in fibroblasts and tumour cells , 2003, The Journal of pathology.
[99] A. Gown,et al. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast , 1999, Virchows Archiv.
[100] Z. Shao,et al. The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. , 1998, Experimental cell research.